Quantitative Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-249,114
Closed -$5.49M 477
2024
Q4
$5.49M Buy
+249,114
New +$5.49M 0.41% 56
2024
Q3
Sell
-24,304
Closed -$394K 436
2024
Q2
$394K Buy
+24,304
New +$394K 0.04% 256
2022
Q4
Sell
-178,831
Closed -$1.44M 332
2022
Q3
$1.44M Buy
+178,831
New +$1.44M 0.24% 106
2022
Q2
Sell
-15,965
Closed -$149K 307
2022
Q1
$149K Buy
+15,965
New +$149K 0.02% 191
2021
Q4
Sell
-80,731
Closed -$786K 449
2021
Q3
$786K Buy
+80,731
New +$786K 0.07% 228
2021
Q2
Sell
-25,059
Closed -$289K 584
2021
Q1
$289K Buy
+25,059
New +$289K 0.02% 415
2020
Q2
Sell
-91,514
Closed -$821K 682
2020
Q1
$821K Buy
+91,514
New +$821K 0.09% 234
2019
Q4
Sell
-996,548
Closed -$6.86M 768
2019
Q3
$6.86M Sell
996,548
-139,732
-12% -$961K 0.37% 76
2019
Q2
$10.5M Buy
1,136,280
+651,280
+134% +$6.01M 0.41% 55
2019
Q1
$7.6M Buy
485,000
+388,900
+405% +$6.1M 0.44% 50
2018
Q4
$1.48M Buy
+96,100
New +$1.48M 0.08% 234
2018
Q2
Sell
-810,700
Closed -$13.9M 925
2018
Q1
$13.9M Buy
810,700
+656,900
+427% +$11.2M 0.24% 96
2017
Q4
$2.91M Sell
153,800
-1,843,400
-92% -$34.9M 0.04% 424
2017
Q3
$35.2M Buy
1,997,200
+1,856,500
+1,319% +$32.7M 0.4% 54
2017
Q2
$4.67M Buy
+140,700
New +$4.67M 0.07% 343
2017
Q1
Sell
-134,900
Closed -$4.89M 897
2016
Q4
$4.89M Buy
+134,900
New +$4.89M 0.12% 261
2016
Q1
Sell
-48,300
Closed -$3.17M 931
2015
Q4
$3.17M Sell
48,300
-118,800
-71% -$7.8M 0.19% 136
2015
Q3
$9.43M Buy
+167,100
New +$9.43M 0.71% 23
2015
Q2
Sell
-105,200
Closed -$6.55M 685
2015
Q1
$6.55M Buy
105,200
+81,400
+342% +$5.07M 0.63% 26
2014
Q4
$1.37M Sell
23,800
-13,700
-37% -$787K 0.21% 103
2014
Q3
$2.02M Buy
+37,500
New +$2.02M 0.39% 46
2014
Q1
Sell
-23,600
Closed -$945K 726
2013
Q4
$945K Buy
+23,600
New +$945K 0.09% 205